
Membio
A leader in single-use bioreactor technology
- Founded
- 2018
- Employees*
- 2-10
- Funding to Date*
- $23K
- Website
- membio.ca
The underlying scientific principles that make unprecedented commercial-scale production of red blood cells possible also make the unprecedented commercial-scale production of other whole cell produts possible as well. Membio's biomanufacturing platform has the potential to radically change the entire cell and gene therapy industy!
Every 2 seconds someone in the U.S. needs blood.